Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026
Go back to Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026| VERASTEM SHS (NASDAQ: VSTM) | Delayed: 7.44 -0.11 (1.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.55 | 52 Week High | $2.43 | |||
| Open | $7.58 | 52 Week Low | $1.05 | |||
| Day High | $7.84 | P/E | N/A | |||
| Day Low | $7.40 | EPS | $-1.79 | |||
| Volume | 4,496,847 | |||||

